By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

f-Star 

Mooslackengasse 17

Vienna    A-1190  Austria
Phone: 43-664-5495688 Fax: 43-1-230-603046


SEARCH JOBS








Company News
f-Star Announces Funding And Collaboration Extension With New Christian Doppler Lab For Innovative Immunotherapeutics 7/14/2016 9:31:02 AM
f-Star Announces An Agreement With CMC Biologics For Manufacture Of mAb2 Bispecific Antibodies 6/7/2016 2:40:58 PM
f-Star Business Update Moves Into New Facility In Cambridge, UK 3/18/2016 10:00:05 AM
f-Star Enters Into Collaborative Discovery & Development Agreement With AbbVie (ABBV) For Bispecific Antibodies In Immuno-Oncology 1/11/2016 6:25:18 AM
f-Star Expands Management Team 11/2/2015 7:50:24 AM
f-Star Announces Publication In Molecular Therapy Of Preclinical Data Evaluating Its Lead Compound FS102 For The Treatment Of HER2-Positive Cancers 10/5/2015 9:54:16 AM
f-Star Approves Novartis AG (NVS)'s Cosentyx for Painful Skin Disease 1/21/2015 4:17:56 PM
Bristol-Myers Squibb Company (BMY) Forges $475 Million Pact For Rights To f-Star's Cancer Drug 10/28/2014 5:57:19 AM
f-Star Announces Formation of New Asset-Centric Vehicle, F-Star Alpha Ltd, With €9.4 Million Series A Investment 10/23/2013 10:13:22 AM
f-Star, Merck Serono Sign $708 Million Deal for Antibody-Derived Therapeutics 9/7/2011 8:02:05 AM
12
//-->